TARS

MKT CAP:$3B

Tarsus Pharmaceuticals Inc

Market Cap

$3B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$59.64-$21.13 (-26.16%)

Jun 8, 2026

52W High $82.5152W Low $38.82

Company Details

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solu...

CEO

—

IPO Date

Oct 16, 2020

Website

tarsusrx.com

Key Metrics TTM

Revenue

$535M

+129.0% YoY

Net Income

-$48M

EPS (Diluted)

Free Cash Flow

-$32M

Revenue / Share

$12.46

Gross Margin

90.4%

Operating Margin

-9.5%

Net Margin

-9.0%

FCF Margin

-5.9%

P/S

4.7x

P/E

Earnings Reports

Q1 2026

May 6, 2026

$162M+106.9%

FY 2025

Feb 23, 2026

$451M+146.7%

Q4 2025

Feb 23, 2026

$152M+128.4%

Q3 2025

Nov 4, 2025

$119M+146.7%

Q2 2025

Aug 6, 2025

$103M+151.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee